DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded by StockNews.com to Buy Rating

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday.

Other analysts have also issued research reports about the stock. Stifel Nicolaus lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Barrington Research restated an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $31.88.

DENTSPLY SIRONA Trading Down 28.0 %

Shares of XRAY opened at $17.26 on Wednesday. DENTSPLY SIRONA has a fifty-two week low of $17.22 and a fifty-two week high of $37.60. The business has a 50-day moving average of $24.82 and a 200 day moving average of $25.98. The firm has a market cap of $3.50 billion, a P/E ratio of -20.07, a price-to-earnings-growth ratio of 1.27 and a beta of 1.02. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of the business. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP purchased a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $27,000. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new position in DENTSPLY SIRONA in the second quarter worth $32,000. Finally, Kennebec Savings Bank bought a new position in DENTSPLY SIRONA in the third quarter valued at $35,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.